This past week I went of in a different route for a little bit as I began to wonder if there was any correlation between COVID and Headache Disorders and if it was possible to learn more about the pathology behind migraines from this disease. The article I reviewed focused on evaluating a patient's condition on a per-case basis to ensure that the patient is getting the best care they can. Next I learnt more about a case in which a patient had COVID-19, but his only substantiated symptom was a headache that was abrupt in onset, holocranial, and throbbing in nature. What I found really intriguing about this case was the fact that no prior history in the cardiovascular tract was reported and due to no symptoms of COVID being present the physicians did not at first think to test the patient. However, I believe this is changing across the profession as before you enter a healthcare setting where you may infect people, one must show a negative test. The final idea I really learned this week was about Angiotensin-converting enzyme 2 and how it allows COVID to affect the trigeminal nerve pathway. I believe that this enzyme could also be looked into as we continue to research the full pathology of Migraine and Headache disorders. I plan on asking Dr. Masrour more about this topic as we meet again next week.
Aniket Hingnekar
Comments